Phase 1b study of R05137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170) Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Yen, C. J.; Carrasquillo, J. A.; Hsu, C. H.; Gansukh, B.; Ma, J.; Hollywood, E.; Wan, P. J.; Shao, Y. Y.; Lin, Z. Z.; Frenette, C.; O'Neil, B. H.; Schwartz, L. H.; Ohtomo, T.; Tanaka, T.; Chen, Y. C.; Ukrainskyj, S.; Saltz, L.; Lee, R.; Cheng, A. L. |
| Abstract Title: | Phase 1b study of R05137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203263 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.4100 |
| Notes: | Meeting Abstract: 4100 -- 50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
